The epigenetic determinants for systemic juvenile idiopathic arthritis phenotyping and treatment response
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The epigenetic determinants for systemic juvenile idiopathic arthritis phenotyping and treatment response ; volume:25 ; number:1 ; day:6 ; month:8 ; year:2024 ; pages:1-10 ; date:12.2024
BMC musculoskeletal disorders ; 25, Heft 1 (6.8.2024), 1-10, 12.2024
- Creator
-
Mosa, Doaa Mosad
Mohsen, Shorouk
Taman, Mohamed
Khaled, Nada
Gaafar, Sherine Mohamed
Abdelhafez, Mona S.
Elmowafy, Rasha
Elnagdy, Marwa H.
Sobh, Ali
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12891-024-07702-9
- URN
-
urn:nbn:de:101:1-2410262101525.597238591738
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mosa, Doaa Mosad
- Mohsen, Shorouk
- Taman, Mohamed
- Khaled, Nada
- Gaafar, Sherine Mohamed
- Abdelhafez, Mona S.
- Elmowafy, Rasha
- Elnagdy, Marwa H.
- Sobh, Ali
- SpringerLink (Online service)
Other Objects (12)
Glucose metabolism in systemic juvenile idiopathic arthritis
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
Extreme thrombocytosis in systemic juvenile idiopathic arthritis. A case report
Novel IL10 gene family associations with systemic juvenile idiopathic arthritis
The role of extracellular histones in systemic-onset juvenile idiopathic arthritis
Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome
Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
INFRAFRONTIER quality principles in systemic phenotyping
Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis
Development of consensus best treatment plans for new-onset systemic juvenile idiopathic arthritis
Glucose metabolism in systemic juvenile idiopathic arthritis
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
Extreme thrombocytosis in systemic juvenile idiopathic arthritis. A case report
Novel IL10 gene family associations with systemic juvenile idiopathic arthritis
The role of extracellular histones in systemic-onset juvenile idiopathic arthritis
Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome
Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
INFRAFRONTIER quality principles in systemic phenotyping
Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis
Development of consensus best treatment plans for new-onset systemic juvenile idiopathic arthritis
Glucose metabolism in systemic juvenile idiopathic arthritis
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
Extreme thrombocytosis in systemic juvenile idiopathic arthritis. A case report
Novel IL10 gene family associations with systemic juvenile idiopathic arthritis
The role of extracellular histones in systemic-onset juvenile idiopathic arthritis
Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome
Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
INFRAFRONTIER quality principles in systemic phenotyping
Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis